Incumaker Inc. update to merger termination with CEN Biotech Inc.

ATLANTA, July 06, 2017 -- INCUMAKER, INC.  (OTC Pink:QMKR), wished to update its shareholders of the previously announced merger termination of CEN Biotech, Inc. with its subsidiary, Eastern Starr Biotech, Inc.

As a result of the termination, Incumaker will not be issuing 100 million shares of common stock to CEN Biotech, nor will it be assuming any debt or liabilities associated with CEN Biotech.  Incumaker has resumed its communications with other potential merger partners with a goal of identifying opportunities that will allow Incumaker to increase shareholder value.

In addition, the Company has retained an auditor to complete its 2 year PCAOB audit and expects the audit to be completed in July 2017.  This is a necessary step for Incumaker to uplist to the OTC QB marketplace and to become a SEC compulsory filer.

About Incumaker:

Incumaker, Inc. (OTC Pink:QMKR) is a diversified holding company whose strategic plan is to acquire interests in young businesses, and provide financing, advice and guidance to assist them in realizing their potential. The company’s wholly owned subsidiary, Eastern Starr Biotech, is pursuing strategic acquisitions in the Cannabis industries.  We continue to identify and evaluate other potential acquisitions that we believe will create shareholder value and return. For additional information please email [email protected].

Company Disclaimers:

As a "penny stock" Company, within the meaning of federal and state securities law, Incumaker, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, Incumaker, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.

Forward-Looking Statements:

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers.

Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission.

Contact:
Incumaker Inc.
[email protected]